Clinical study on external application of Natrii Sulfas to prevent post-ERCP pancreatitis in children

Kaihua YANG; Wenyu WANG; Jingqing ZENG; Tianao ZHANG; Jiayu ZHANG; Biao GONG; Zhaohui DENG

doi:10.16305/j.1007-1334.2021.2101024

您当前的位置：

首页 >

文章列表页 >

Clinical study on external application of Natrii Sulfas to prevent post-ERCP pancreatitis in children

更新时间：2022-08-03

- Clinical study on external application of Natrii Sulfas to prevent post-ERCP pancreatitis in children
- Shanghai Journal of Traditional Chinese Medicine Vol. 55, Issue 9, Pages: 60-63(2021)
- 作者机构：
  
  1.上海交通大学医学院附属上海儿童医学中心消化科（上海　200127）
  2.上海中医药大学附属曙光医院脾胃病科（上海　201203）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2021.2101024
  CLC：
扫描看全文
Kaihua YANG, Wenyu WANG, Jingqing ZENG, et al. Clinical study on external application of Natrii Sulfas to prevent post-ERCP pancreatitis in children. [J]. Shanghai Journal of Traditional Chinese Medicine 55(9):60-63(2021)
DOI：

Kaihua YANG, Wenyu WANG, Jingqing ZENG, et al. Clinical study on external application of Natrii Sulfas to prevent post-ERCP pancreatitis in children. [J]. Shanghai Journal of Traditional Chinese Medicine 55(9):60-63(2021) DOI： 10.16305/j.1007-1334.2021.2101024.

摘要

目的,2,观察芒硝外敷对儿童内镜逆行性胰胆管造影（ERCP）术后胰腺炎（PEP）的预防作用。,方法,2,将150例拟行ERCP术的胆胰疾病患儿随机分为治疗组和对照组，每组75例。两组均按操作规范行ERCP术，治疗组在术前30 min给予芒硝外敷并持续使用至术后24 h。观察PEP发生率，比较术后VAS疼痛评分及血清肿瘤坏死因子-α（TNF-α）、白介素-6（IL-6）、二胺氧化酶（DAO）、D-乳酸水平的变化情况。,结果,2,①治疗组、对照组PEP发生率分别为5.3%、18.7%，治疗组PEP发生率低于对照组（,P,<,0.05）。②术后24 h组间比较，治疗组VAS疼痛评分低于对照组（,P,<,0.05）。③术后24 h与术前3 h组内比较，两组血TNF-α、IL-6水平升高（,P,<,0.05），血DAO、D-乳酸水平降低（,P,<,0.05）；术后24 h组间比较，治疗组血TNF-α、IL-6、DAO、D-乳酸水平均低于对照组（,P,<,0.05）。,结论,2,芒硝外敷能有效预防PEP的发生并减轻ERCP术后疼痛，对胰腺组织有一定的保护作用，其机制可能与改善炎症反应、保护肠黏膜屏障功能有关。

Abstract

Objective,2,To observe the preventive effect of external application of Natrii Sulfas on post-ERCP pancreatitis (PEP) in children.,Methods,2,A total of 150 children with cholangiopancreatic diseases undergoing ERCP were randomly divided into treatment group (,n,=75) and control group (,n,=75). ERCP was performed according to the operation standard in both groups. In the treatment group, Natrii Sulfas was applied externally 30 minutes before operation and continued to be used until 24 hours after operation. The incidence of PEP was observed, and the postoperative VAS pain score and the changes of blood tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), diamine oxidase (DAO) and D-lactic acid were compared.,Results,2,①The incidence of PEP in the treatment group and the control group was 5.3% and 18.7% respectively, and the incidence of PEP in the treatment group was lower than that in the control group (,P,<,0.05). ②The VAS pain score in the treatment group was lower than that in the control group 24 hours after operation (,P,<,0.05). ③Compared with the results 3 hours before operation, the levels of blood TNF-α and IL-6 increased and the levels of DAO and D-lactic acid decreased in both groups 24 hours after operation (,P,<,0.05). Otherwise, the levels of blood TNF-α, IL-6, DAO and D-lactic acid in the treatment group were lower than those in the control group 24 hours after operation (,P,<,0.05).,Conclusions,2,External application of Natrii Sulfas can effectively prevent the incidence of PEP, relieve post-ERCP pain and protect pancreatic tissues to some extent. The mechanism may be related to its functions of improving inflammatory response and protecting intestinal mucosal barrier.

关键词

内镜逆行性胰胆管造影术后胰腺炎儿童芒硝外敷炎症黏膜屏障

Keywords

ERCPpost-operationpancreatitischildrenNatrii Sulfasexternal applicationinflammationmucosal barrier

references

MUFTAH M, SHAH R, FRITZEN C, et al. Endoscopic retrograde cholangiopancreatography in pediatric populations[J]. Curr Treat Options Gastroenterol, 2019, 17(1): 165-170.

ROENDLE D M, ABRAHAM O, HUANG R, et al. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population[J]. Gastrointest Endosc, 2015, 81(6): 1408-1416.

USATIN D, FERNANDES M, ALLEN I E, et al. Complications of endoscopic retrograde cholangiopancreatography in pediatric patients; A systematic literature review and meta-analysis[J/OL]. J Pediatr, 2016, 179: 160-165[2020-12-30]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123955/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123955/.

KOCHAR B, AKSHINTALA V S, AFGHANI E, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled review by using randomized, controlled trials[J]. Gastrointest Endosc, 2014, 81(1): 143-149.

陈萌，丛军，李甫，等. 芒硝外敷对ERCP术后急性胰腺炎模型大鼠的防治作用及其机制研究[J]. 上海中医药杂志，2020, 54(S1): 162-166.

COTTON P B. Fifty years of ERCP: a personal review[J]. Gastrointest Endosc, 2018, 88(2): 393-396.

WANG Z K, YANG Y S, CAI F C, et al. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial[J]. Chin Med J, 2013, 126(13): 2403-2408.

LIU L, LI C H, HUANG Y, et al. Nonsteroidal anti-inflammatory drugs for endoscopic retrograde cholangiopancreatography postoperative pancreatitis prevention: a systematic review and meta-analysis[J]. J Gastrointest Surg, 2019, 23(10): 1991-2001.

ANDRADE-DÁVILA V F, CHÁVEZ-TOSTADO M, DÁVALOS-COBIÁN C, et al. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial[J]. BMC Gastroenterol, 2015(15): 85.

DAI H F, WANG X W, ZHAO K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis[J]. Hepatobiliary Pancreat Dis Int, 2009, 8(1): 11-16.

TAN C C, LING Z X, HUANG Y, et al. Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis[J]. Pancreas, 2015, 44(6): 868-875.

崔勇鹤，王文俊. 重症急性胰腺炎肠道屏障障碍及治疗研究进展[J]. 临床急诊杂志，2019, 20(1): 77-81.

张妮，朱保权，张庆立，等.危重症患儿血浆D-乳酸水平和二胺氧化酶活性与胃肠功能障碍关系研究[J]. 临床儿科杂志，2006, 24(10): 794-796.

丁春龙，王玉海，杨理坤，等. 血清D-乳酸、细菌内毒素及二胺氧化酶在创伤性颅脑损伤后肠道黏膜屏障功能评估中的作用[J]. 中华神经外科杂志，2019, 35(12): 1258-1261.

龚玉婷，黄丹，陈志芬. 急性胰腺炎患者早期血清D-乳酸、内毒素及二胺氧化酶在病情评估中的价值[J]. 武汉大学学报（医学版），2019, 40(1): 112-115.

谢齐贵，陈湛，朱世峰，等. 急性胰腺炎患者早期血清D-乳酸、内毒素、DAO水平及临床意义[J]. 重庆医学，2020, 49(9): 1421-1424.

姜雯，郝伟，张风芝. 不同方式营养支持对重症急性胰腺炎患者血浆DAO及D-乳酸水平的影响[J]. 山东医药，2010, 50(43): 105-106.

WANG Y X, ZHANG X H, LIA C Y. Applying hot compresses with rhubarb and mirabilite to reduce pancreatic leakage occurrence in the treatment of severe acute pancreatitis[J]. Iran J Public Health, 2017, 46(1): 136-138.

夏庆，邓力珲. 中西医结合治疗重症急性胰腺炎的几个热点问题[J]. 四川大学学报（医学版），2013, 44(6): 962-965.

马悦，黄宗文，夏庆，等. 中西医结合治疗对重症急性胰腺炎患者血清抵抗素的影响：随机对照临床试验[J]. 中西医结合学报，2009, 7(12): 1134-1138.

Views

163

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Shanghai Style of Xu’s Pediatrics’ experience in treating children’s combined allergic rhinitis and asthma syndrome

Experience of Yu Jian in treating children with SARS⁃CoV⁃2 infection——A proven critical case

Clinical study on intervention of Fuzheng Hejie Recipe in children with asymptomatic infection of SARS⁃CoV⁃2 Omicron variant

Regulatory effect of miR⁃155 on progress of the subacute thyroditis inflammatory response

Expert consensus on prevention and treatment of children’s respiratory diseases by Shanghai style acupoint application for treating winter diseases in summer （2022）

Related Author

No data

Related Institution

Institute of Pediatrics， Shanghai Academy of Traditional Chinese Medicine

Department of Pediatrics， Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Respiratory， Fudan University of Children’s Hospital

Department of Infectious Disease， Fudan University of Children’s Hospital

Department of Intensive Care Unit， Fudan University of Children’s Hospital

⁰